Digital Breast Tomosynthesis System Market

Digital breast tomosynthesis (DBT) is a 3D breast imaging technique built on full field digital mammography technology. DBT systems create multiple projection images of the breasts obtained from different angles of the rotating X-Ray tube at a low radiation dose through the compressed breast. Images are reconstructed into multiple slices of 1mm thickness and viewed on a dedicated monitor approved for tomosynthesis. This minimizes the impact of tissue superimposition resulting in better visualization of the internal structures. Conventionally, breast screening was performed step by step, starting with full-field digital mammography (FFDM or 2D mammography) followed by digital breast tomosynthesis (3D mammography) or breast Magnetic Resonance Imaging (MRI). FFDM is considered the gold standard in breast cancer screening. However, with the advent of DBT technology, it is slowly being replaced. DBT is frequently used as an adjunct technique with FFDM. Research and studies are being undertaken to consider DBT as a primary screening tool, particularly in patients with dense breasts. 3D mammography has proven to be better than 2D mammography in multiple clinical trials, which has led to an increase in its adoption. Combination of 2D and 3D mammography has become the new standard of care since 3D mammography compliments conventional 2D mammography. The purpose of our study was to comprehensively characterize the dosimetrist properties of a clinical DBT system for the acquisition of mammographic and tomosynthesis images.

Digital Breast Tomosynthesis System Market contains market size and forecasts of Digital Breast Tomosynthesis (DBT) System in global, including the following market information:

Global Digital Breast Tomosynthesis (DBT) System Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Digital Breast Tomosynthesis (DBT) System Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Digital Breast Tomosynthesis (DBT) System companies in 2021 (%)

The global Digital Breast Tomosynthesis (DBT) System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2D Digital Mammography Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Digital Breast Tomosynthesis (DBT) System include Hologic, GE Healthcare, Siemens, I.M.S., PLANMED OY, XinRay Systems and FUJIFILM, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Digital Breast Tomosynthesis (DBT) System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Digital Breast Tomosynthesis (DBT) System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Digital Breast Tomosynthesis (DBT) System Market Segment Percentages, by Type, 2021 (%)

2D Digital Mammography Technology

3D Digital Mammography Technology

Global Digital Breast Tomosynthesis (DBT) System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Digital Breast Tomosynthesis (DBT) System Market Segment Percentages, by Application, 2021 (%)

Hospitals

Diagnostic Centers

Others

Global Digital Breast Tomosynthesis (DBT) System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Digital Breast Tomosynthesis (DBT) System Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Digital Breast Tomosynthesis (DBT) System revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Digital Breast Tomosynthesis (DBT) System revenues share in global market, 2021 (%)

Key companies Digital Breast Tomosynthesis (DBT) System sales in global market, 2017-2022 (Estimated), (Units)

Key companies Digital Breast Tomosynthesis (DBT) System sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Hologic

GE Healthcare

Siemens

I.M.S.

PLANMED OY

XinRay Systems

FUJIFILM